fbpx

Rapid treatments for depression: Endocannabinoid system as a therapeutic target

Current first-line treatments for major depressive disorder (MDD), i.e., antidepressant drugs and psychotherapy, show delayed onset of therapeutic effect as late as 2–3 weeks or more. In the clinic, the speed of beginning of the actions of antidepressant drugs or other interventions is vital for many reasons.

The post Rapid treatments for depression: Endocannabinoid system as a therapeutic target appeared first on Society of Cannabis Clinicians.

Leave a Reply

%d bloggers like this: